Literature DB >> 32807861

Spatial resolution of SARS-CoV-2 lung infection.

Luisanna Pia1.   

Abstract

Entities:  

Year:  2020        PMID： 32807861      PMCID： PMC7430090          DOI： 10.1038/s41577-020-00432-8

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  1 in total

1.  Rates of COVID-19-related Outcomes in Cancer compared to non-Cancer Patients.

Authors:  Lova Sun; Sanjna Surya; Anh N Le; Heena Desai; Abigail Doucette; Peter Gabriel; Marylyn Ritchie; Daniel Rader; Ivan Maillard; Erin Bange; Alexander Huang; Robert H Vonderheide; Angela DeMichele; Anurag Verma; Ronac Mamtani; Kara N Maxwell
Journal:  medRxiv       Date:  2020-08-15
  1 in total
  3 in total

1.  Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.

Authors:  Ramesh K Paidi; Malabendu Jana; Rama K Mishra; Debashis Dutta; Kalipada Pahan
Journal:  J Immunol       Date:  2021-10-13       Impact factor: 5.422

2.  ACE-2-interacting Domain of SARS-CoV-2 (AIDS) Peptide Suppresses Inflammation to Reduce Fever and Protect Lungs and Heart in Mice: Implications for COVID-19 Therapy.

Authors:  Ramesh K Paidi; Malabendu Jana; Rama K Mishra; Debashis Dutta; Sumita Raha; Kalipada Pahan
Journal:  J Neuroimmune Pharmacol       Date:  2021-01-11       Impact factor: 7.285

3.  Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses.

Authors:  Ramesh Kumar Paidi; Malabendu Jana; Sumita Raha; Mary McKay; Monica Sheinin; Rama K Mishra; Kalipada Pahan
Journal:  J Neuroimmune Pharmacol       Date:  2021-10-22       Impact factor: 7.285
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.